echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Review of the 2021 ADA Guidelines: "Glucose-lowering Drug Specificity and Patient Factors" Overview Knowledge Card

    Review of the 2021 ADA Guidelines: "Glucose-lowering Drug Specificity and Patient Factors" Overview Knowledge Card

    • Last Update: 2021-06-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Edited by Yimaitong, please do not reprint without authorization
    .

    The 81st Scientific Meeting of the American Diabetes Association (ADA) in 2021 will open on the 25th of this month for 5 days
    .

    As in previous years, Yimaitong has been authorized by the ADA Conference Affairs Group to report on this conference
    .

    The exciting content will be revealed in advance: Looking at the conference schedule, this year's ADA conference will have draft guidelines for diagnosis and treatment of type 1 diabetes and a number of major research releases.
    For more content, please continue to pay attention to the Endocrinology Department of Yimaitong
    .

    On this occasion, let’s review the 2021 ADA guidelines just released at the beginning of this year
    .

    This article selects the relevant content of "Drug specificity and patient factors in the selection of hypoglycemic drugs for type 2 diabetes" in the 2021 ADA guidelines to share with you
    .

    Figure 1 Drug specificity and patient factors in the choice of hypoglycemic drugs for type 2 diabetes Reference materials: Cai Jinghao, Zhou Jian.
    Chinese Journal of Medical Frontiers (Electronic Edition), 2021, 13(02): 13-23.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.